Sentences with phrase «lung cancer patients»

Study: Walking could improve the sleep of lung cancer patients.

The same benefits of increased activity observed in lung cancer patients, especially improved symptoms and quality of life, appear to apply to lung cancer survivors as well.

We hope that it may increase survival rates for lung cancer patients.

Fifty percent of newly diagnosed lung cancer patients are former smokers [4].

Of the high - risk lung cancer patients, about 75 percent were alive a year after they began using the app.

A web and smartphone app, however, offers lung cancer patients a chance for longer survival.

Clinical responses in lung cancer patients have been impressive, with responses in patients with advance disease whose cancers did not respond to other treatment approaches.

Investing in the continuity of care for lung cancer patients can bring tremendous benefits in terms of patient satisfaction and quality of life.

«As the population of the United States ages, there will be a higher number of lung cancer patients with comorbidities at diagnosis.»

The international early Phase II trial led by a team based at the Oxford Cancer Research Centre will trial the experimental drug called LY2181308 with advanced non-small cell lung cancer patients who no longer respond to platinum chemotherapy - the standard initial treatment for this group.

The clinical activity of durvalumab plus tremelimumab in non-small cell lung cancer patients appears to be greater than either agent alone, as reported in prior studies.

The study used samples from lung cancer patients with brain metastases.

«Delay in treatment, missed diagnostic testing found among lung cancer patients.»

«What is particularly encouraging is that we are now able to select, based on features in the tumor, approximately a quarter of advanced lung cancer patients who can receive immunotherapy as their initial treatment.

Duesberg's model resembles ideas advanced by some other researchers, including Henry H.Q. Heng, a molecular geneticist at Wayne State University, as well as Mark David Vincent, who treats lung cancer patients at the London Health Sciences Centre in Ontario, Canada.

«More early stage lung cancer patients survive the disease: Study shows surgery and radiation make life - saving difference, but too many patients remain untreated.»

The drug is given to a subset of lung cancer patients at a daily dose of 150 mg, but whether this dosing strategy was the best way to prolong survival had not been empirically tested.

The Comprehensive Cancer Center of Wake Forest Baptist Medical Center is one of only a handful of cancer centers that is attempting to give lung cancer patients out of treatment options a chance to keep the cancer at bay.

Continuing the study between Salk and UCLA, Shaw and Shackelford coordinated teams in both locations to perform further testing on mice with earlier stage disease, using cutting - edge imaging technologies just like those used on lung cancer patients in the clinic.

These results should support the idea that IMRT is the radiation therapy of choice for lung cancer patients as well.

«Process to help personalize treatment for lung cancer patients developed.»

The company actually beat Wall Street profit estimates largely thanks to its superstar cancer immunotherapy drug Keytruda, which has been shown to best chemotherapy in helping lung cancer patients live longer and given Merck a leg up over rivals like Bristol - Myers Squibb's immune therapy Opdivo.

If hypofractionated radiation with curative intent can reduce the treatment time for lung cancer patients by half with no greater toxicity, and with equivalent — if not better — tumor control and survival outcomes, this research could result in a change in the paradigm of how a large subset of locally advanced NSCLC patients are treated.»

Dr. Glen Weiss, M.D., M.B.A., is the first author of the study abstract: Phase Ib / II Study of Pembrolizumab plus Chemotherapy in Advanced Cancer: Results of lung cancer patients receiving (at least) 1 prior line of therapy.

Key findings in this study show that 5 - year survival for older lung cancer surgery patients is favorable; surgeons will be able to better individualize care for older lung cancer patients based on newly and uniquely linked data, and the prevalence of lung cancer is expected to increase as the population continues to age.

Mutations in the gene encoding Importin - 11 have been identified in human cancers, and Trotman and colleagues found that tumors from lung cancer patients lacking Importin - 11 tended to show low PTEN levels as well.

Perioperative exercise in lung cancer patients appears to be safe with improvement in operability, operative risk, post-operative complications, as well as increase exercise capacity.

Most lung cancer patients undergo 4D CT as standard - of - care to help radiation oncologists develop a personalized plan to account for breathing motion during therapy.

«In this study, outcomes for HER2 - positive lung cancer patients treated with conventional therapies were similar to outcomes for HER2 - negative patients treated in the same way.

Fewer than 10 per cent of lung cancer patients survive the disease beyond five years after diagnosis.

A new study found that IMRT had better results and less side effects on lung cancer patients compared to traditional radiation therapy.

Both of the researchers, who are in their early forties, said they were motivated by the need to give lung cancer patients better options.

«Many lung cancer patients have their diagnosis made by fine needle aspirate — doctors extract cells via a long needle.

Comparison of smoking and non-smoking lung cancer patients finds differences in clinical signs and survival rates.

That seems to have paid off — the FDA approved the medication without requiring a diagnostic and the company claims that 60 % of new, treatment - eligible lung cancer patients are prescribed Opdivo.

The drug had $ 942 million in global 2015 sales (versus $ 566 million for Keytruda) and, according to the company, has been prescribed to 60 % of new lung cancer patients.

Related Articles: Merck's Keytruda held back by docs who don't want to wait for diagnostics Bristol's Opdivo - Yervoy combo ups response rates in first - line lung cancer patients Roche's Tecentriq bursts onto immuno - oncology scene, with Merck and BMS in its sights Bristol - Myers» new Opdivo ad touts biomarker advantage over Merck's Keytruda Merck's Keytruda lines up its survival data for stepped - up battle with BMS» Opdivo

A bipolar person's lack of compliance with his prescribed drug regime, a recovering lung cancer patient's return to smoking and a heart transplant recipient's relapse into poor eating and exercise habits are rooted in complex dynamics, and the moral dimension can not be evaded.

A lung cancer specialist, Wrangle said 75 percent of lung cancer patients unfortunately are diagnosed at an incurable stage.

«Hypofractionated radiation therapy can halve treatment time for poor performance status lung cancer patients.»

Unfortunately, the treatment had little effect on the survival of the terminally ill lung cancer patients in the first trial.

Findings were presented at the WCLC are based on the updated results of 12 lung cancer patients enrolled in the clinical trial with pembro and irinotecan or gemcitabine with or without vinorelbine or docetaxel.

«Link between inherited genetic variations, outcomes of non-small cell lung cancer patients discovered.»

Recent findings suggest a novel positron emission tomography (PET) imaging approach determining epidermal growth factor receptor (EGFR) mutation status for improved lung cancer patient management.

Published in the Journal of Clinical Investigation, the study collected metabolic data directly from more than 120 human lung cancer patients.

«Physical activity benefits lung cancer patients, survivors.»

D'Incecco's group studied the expression of PD - L1 and PD - 1 in a group of 123 non-small-cell lung cancer patients.